RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/28232469http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/28232469http://www.w3.org/2000/01/rdf-schema#comment"Despite the identification of several oncogenic driver mutations leading to constitutive JAK-STAT activation, the cellular and molecular biology of myeloproliferative neoplasms (MPN) remains incompletely understood. Recent discoveries have identified underlying disease-modifying molecular aberrations contributing to disease initiation and progression. Here, we report that deletion of Nol3 (Nucleolar protein 3) in mice leads to an MPN resembling primary myelofibrosis (PMF). Nol3-/- MPN mice harbor an expanded Thy1+LSK stem cell population exhibiting increased cell cycling and a myelomonocytic differentiation bias. Molecularly, this phenotype is mediated by Nol3-/--induced JAK-STAT activation and downstream activation of cyclin-dependent kinase 6 (Cdk6) and MycNol3-/- MPN Thy1+LSK cells share significant molecular similarities with primary CD34+ cells from PMF patients. NOL3 levels are decreased in CD34+ cells from PMF patients, and the NOL3 locus is deleted in a subset of patients with myeloid malignancies. Our results reveal a novel genetic PMF-like mouse model and identify a tumor suppressor role for NOL3 in the pathogenesis of myeloid malignancies."xsd:string
http://purl.uniprot.org/citations/28232469http://purl.org/dc/terms/identifier"doi:10.1084/jem.20162089"xsd:string
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/author"Mitchell K."xsd:string
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/author"McMahon C."xsd:string
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/author"Hirsch C."xsd:string
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/author"Kitsis R.N."xsd:string
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/author"Walter D."xsd:string
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/author"Maciejewski J.P."xsd:string
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/author"Makishima H."xsd:string
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/author"Gritsman K."xsd:string
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/author"Bartholdy B."xsd:string
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/author"Stanley R.F."xsd:string
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/author"Steidl U."xsd:string
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/author"Todorova T.I."xsd:string
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/author"Will B."xsd:string
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/author"McKimpson W.M."xsd:string
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/author"Piszczatowski R.T."xsd:string
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/author"Narayanagari S."xsd:string
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/date"2017"xsd:gYear
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/name"J Exp Med"xsd:string
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/pages"753-771"xsd:string
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/title"A myeloid tumor suppressor role for NOL3."xsd:string
http://purl.uniprot.org/citations/28232469http://purl.uniprot.org/core/volume"214"xsd:string
http://purl.uniprot.org/citations/28232469http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/28232469